Effects of Rosuvastatin with Different Doses of Statins Atorvastatin on Inflammatory Factors in Patients with Acute Coronary Syndrome
Wang Ai-qi
Abstract
Wang Ai-qi
Abstract
Objective:To investigate the effects of different dose of atorvastatin and rosuvastatin treatment comprehensive clinical effect in patients with acute coronary syndrome.Methods:According to the different treatment 135 cases of acute coronary syndrome patients were grouped,rosuvastatin group 45cases(10mg rosuvastatin),atorvastatin group A 45cases(10mg atorvastatin)and atorvastatin group B 45cases(20mg atorvastatin),the changes of blood lipid the inflammatory factor and compared before and after treatment in three groups.Results:Rosuvastatin,atorvastatin group B in patients with PAI-1,MMP-9,TC,LDL-C decreased significantly better than atorvastatin group A,P0.05;rosuvastatin no significant correlation between the changes of serum levels of inflammatory factors in the atorvastatin group and blood lipid level.Conclusion:The use of rosuvastatin and atorvastatin treatment ACS can effectively make inflammation factors level in serum decreased,and the decreased effect of drug related with measurement.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of different dose of atorvastatin and rosuvastatin treatment comprehensive clinical effect in patients with acute coronary syndrome.Methods:According to the different treatment 135 cases of acute coronary syndrome patients were grouped,rosuvastatin group 45cases(10mg rosuvastatin),atorvastatin group A 45cases(10mg atorvastatin)and atorvastatin group B 45cases(20mg atorvastatin),the changes of blood lipid the inflammatory factor and compared before and after treatment in three groups.Results:Rosuvastatin,atorvastatin group B in patients with PAI-1,MMP-9,TC,LDL-C decreased significantly better than atorvastatin group A,P0.05;rosuvastatin no significant correlation between the changes of serum levels of inflammatory factors in the atorvastatin group and blood lipid level.Conclusion:The use of rosuvastatin and atorvastatin treatment ACS can effectively make inflammation factors level in serum decreased,and the decreased effect of drug related with measurement.
Key concepts: Atorvastatin, Rosuvastatin, Medicine, Acute coronary syndrome, Internal medicine, Blood lipids, Gastroenterology, Pharmacology